Deciphering the role of a SINE-VNTR-Alu retrotransposon polymorphism as a biomarker of Parkinson's disease progression

Sci Rep. 2024 May 13;14(1):10932. doi: 10.1038/s41598-024-61753-5.

Abstract

SINE-VNTR-Alu (SVA) retrotransposons are transposable elements which represent a source of genetic variation. We previously demonstrated that the presence/absence of a human-specific SVA, termed SVA_67, correlated with the progression of Parkinson's disease (PD). In the present study, we demonstrate that SVA_67 acts as expression quantitative trait loci, thereby exhibiting a strong regulatory effect across the genome using whole genome and transcriptomic data from the Parkinson's progression markers initiative cohort. We further show that SVA_67 is polymorphic for its variable number tandem repeat domain which correlates with both regulatory properties in a luciferase reporter gene assay in vitro and differential expression of multiple genes in vivo. Additionally, this variation's utility as a biomarker is reflected in a correlation with a number of PD progression markers. These experiments highlight the plethora of transcriptomic and phenotypic changes associated with SVA_67 polymorphism which should be considered when investigating the missing heritability of neurodegenerative diseases.

MeSH terms

  • Alu Elements* / genetics
  • Biomarkers
  • Disease Progression*
  • Humans
  • Minisatellite Repeats* / genetics
  • Parkinson Disease* / genetics
  • Polymorphism, Genetic*
  • Quantitative Trait Loci
  • Retroelements* / genetics
  • Short Interspersed Nucleotide Elements / genetics

Substances

  • Retroelements
  • Biomarkers